Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 356 shares at $16.63 ($6K) on 2019-03-18, disclosed to the SEC on 2019-03-19.
Scheduled sale ($6k) by Executive VP, Global R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.63 | 93 | $2K | 26.1% |
| 2 | $16.63 | 263 | $4K | 73.9% |
| Total | $16.63 avg | 356 | $6K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |